Diabetic cardiomyopathy is marked by reduced expression of fusion proteins (Mfn1, Mfn2, OPA1), increased fission, and overproduction of reactive oxygen species (ROS), which contribute to insulin resistance and cardiac dysfunction. This evidence concerns the gene OPA1 and diabetic cardiomyopathy.